Last year, the Semiconductor Research Corporation and the Defense Advanced Research Projects Agency announced a new program to improve the nation’s information and technology infrastructure. With a global chip shortage, supply chain issues, and other challenges in play, a group of Georgia Tech faculty members jumped at the opportunity to participate.
Students in the Fall 2016 first-year cohort recorded a six-year graduation rate of 93%, an all-time high for the Institute.
Messenger RNA, or mRNA, has been used to immunize millions of people in the past few years. Now, a research team led by Georgia Tech has developed an mRNA treatment designed to be used in a common nebulizer, targeting diseases such as influenza, asthma, and cystic fibrosis.
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
Georgia Institute of Technology | Institute Communications | 177 North Avenue NW | Atlanta, GA 30332 US
This email was sent to .
To continue receiving our emails, add us to your address book.